From a lone clinic in Texas to an entire school district in North Dakota, the virus is upending daily life and revealing a deeper crisis of belief.

Hepatitis B virus-induced hepatocellular carcinoma (HCC) remains a major global health burden, and new therapeutic and diagnostic approaches are urgently needed. Emerging research highlights the ...

MASH improvement was defined as a decrease of at least 2 points in nonalcoholic fatty liver disease activity score (NAS) or a NAS of ≤3 points. Resolution of MASH was defined as a hepatocellular ...

“These findings suggest that semaglutide may prevent fatty liver disease from progressing to cirrhosis and can indeed reverse the course of the disease,” said Arun J. Sanyal, MD, study author ...

The phase 1 clinical trial of anti–PD-1 ab plus intrahepatic injection of oncolytic virus (OH2) combined radiotherapy of liver metastasis in stage IV melanoma.

Adult patients with metabolic dysfunction–associated steatohepatitis (MASH) and moderate or advanced liver fibrosis showed improved liver histology with a once-weekly dose of semaglutide (Wegovy ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared with placebo.

Dextromethorphan, which is used to relieve cough, can cause side effects. Learn about its more common, mild, and serious side effects and how to manage them.

Key Data Highlights: The composite MASHResInd score is a robust, non-invasive marker for liver histology improvement, with potential application across clinical research and practice.

Researchers at Peking University have discovered that a filamentous gut fungus, Fusarium foetens, can reverse metabolic dysfunction–associated steatohepatitis (MASH) in mice. These findings have ...

Your brain and body literally “sync” with music, according to new research. Instead of just understanding rhythm, our neural circuits physically resonate with it—shaping how we feel and move ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic dysfunction-associated steatohepatitis and moderate or advanced liver ...